Scoring systems give a check-list and methodological informations whic
h have to be found in controlled therapeutic trials reports and papers
. These systems try to quantify each item to give a global score. The
Chalmer's list is the most wellknown. It allows a balance in scoring t
aking in account the qualify of the endpoints. Other lists are more si
mple. Many check-lists allow the scoring of the methodological design
or the statistical analysis. In all systems the major methodological p
oints are : the randomization, the description of the population, the
double blind, the estimation of the sample size, the handling of withd
rawal and drop out, the major endpoint, the patients follow-up, the st
atistical analysis and the data presentation. All these scoring system
s have several limits: the quantitative evaluation of each item is sub
jective and the point scoring has never been validated, some scoring s
ystems are old and don't integrate new methodological methods, the sco
res never included the clinical interest of the trial, some items are
questionable, others are forgotten (intention to treat analysis, steer
ing comity...). Scoring systems allow a control of the methodological
qualify of clinical trials but don't include the clinical or scientifi
c interest of the study. These systems are a useful methodological too
l for publication process in medical journals and for new drugs author
ization. The evaluation by authors themselves of the quality of their
papers using a standardized scoring system could clarify the reviewers
decisions.